Yuko Yamazaki

Yuko Yamazaki

Auto-generated profile, based on publicly available information

Yuko Yamazaki

Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2017 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
TMTomoaki Morioka
Tomoaki Morioka
MEMasanori Emoto
Masanori Emoto
YYYuko Yamazaki
Yuko Yamazaki
MKMasafumi kurajoh
Masafumi kurajoh
KMKoka Motoyama
Koka Motoyama
MIMasaaki Inaba
Masaaki Inaba
Aims/Introduction: A soluble form of the leptin receptor (soluble Ob‐R) in the circulation regulates leptin's bioactivity, and is inversely associated with body adiposity and circulating leptin levels. However, no study has examined the clinical impact of soluble Ob‐R on glucose metabolism in diabetes. The present study aimed to investigate the association of plasma soluble Ob‐R levels with insulin resistance and pancreatic β‐cell function in patients with type 2 diabetes.Materials and Methods: A total of 289 Japanese patients with type 2 diabetes were included in the present study. Fasting plasma soluble Ob‐R levels and plasma leptin levels were measured by enzyme‐linked immunosorbent assay. Insulin resistance and pancreatic β‐cell function were estimated by homeostasis model assessment of insulin resistance, homeostasis model assessment of β‐cell function and fasting C‐peptide index.Results: The median plasma soluble Ob‐R level and plasma leptin level were 3.4 ng/mL and 23.6 ng/mL, respectively. Plasma soluble Ob‐R levels were negatively correlated with homeostasis model assessment of insulin resistance, homeostasis model assessment of β‐cell function and the C‐peptide index, whereas plasma leptin levels were positively correlated with each index in univariate analyses. Multivariate analyses including plasma soluble Ob‐R levels, plasma leptin levels and use of sulfonylureas, along with age, sex, body mass index and other covariates, showed that soluble Ob‐R levels were independently and negatively associated with homeostasis model assessment of β‐cell function and the C‐peptide index, but not significantly associated with homeostasis model assessment of insulin resistance.Conclusions: Plasma soluble Ob‐R levels are independently associated with pancreatic β‐cell function, but not with insulin resistance, in patients with type 2 diabetes. The present study implicates the role of soluble Ob‐R in pancreatic β‐cell dysfunction in type 2 diabetes.

26 February 2018 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
THTomoe Hirota
Tomoe Hirota
TMTomoaki Morioka
Tomoaki Morioka
KYKoichiro Yoda
Koichiro Yoda
NTNorikazu Toi
Norikazu Toi
NHNoriyuki Hayashi
Noriyuki Hayashi
MIMasaaki Inaba
Masaaki Inaba
Aims/Introduction: Poor sleep quality is associated with obesity and diabetes. The adipocyte‐derived hormone, leptin, was recently shown to underlie the link between abnormal sleep and obesity. We aimed to investigate the association between leptin and sleep quality in type 2 diabetes patients.Materials and Methods: In the present cross‐sectional study, we studied 182 type 2 diabetes patients, among whom 113 were diagnosed with obesity (body mass index ≥25 kg/m2). Fasting plasma leptin levels were measured, and sleep architecture was assessed using single‐channel electroencephalography.Results: Using unadjusted analyses, the obese type 2 diabetes patients, but not their non‐obese counterparts, showed a positive correlation between plasma leptin levels and a parameter for deep sleep assessed by delta power during the first sleep cycle. Multivariate analysis showed that plasma leptin levels were positively associated with delta power, but not with the total sleep time, after adjusting for potential confounders including age, body mass index and the apnea–hypopnea index, in the obesity group. However, neither delta power nor total sleep time was associated with leptin in the non‐obesity group.Conclusions: Plasma leptin levels are independently associated with sleep quality in obese, but not in non‐obese, type 2 diabetes patients. The present study indicates a favorable relationship between leptin and sleep quality in obese type 2 diabetes patients.

1 January 2016 in Journal of Atherosclerosis and Thrombosis
Verified
Journal Article
Open access
PDF file
HMHirokazu Morigami
Hirokazu Morigami
TMTomoaki Morioka
Tomoaki Morioka
YYYuko Yamazaki
Yuko Yamazaki
SISatoshi Imamura
Satoshi Imamura
RNRyutaro Numaguchi
Ryutaro Numaguchi
MIMasaaki Inaba
Masaaki Inaba
Aim : Visceral fat accumulation is known to underlie the clustering of cardiovascular risk factors. However, it is not completely understood how visceral fat accumulation influences the development of cardiovascular disease. In this study, we investigated the clinical impact of visceral adiposity on vascular stiffness and thickness in patients with type 2 diabetes (T2D). Methods : One hundred and sixty-one patients with T2D, including 92 men and 69 women, were included in this cross-sectional study. Visceral fat area (VFA) and subcutaneous fat area (SFA) were measured by dual bioelectrical impedance analysis. Stiffness parameter β and intima-media thickness (IMT) of the common carotid artery were measured by ultrasonography. Results : The mean age and duration of diabetes in the study population were 61 years and 13.9 years, respectively. In men, VFA and waist circumference (WC) were positively correlated with stiffness parameter β, whereas body mass index (BMI), WC, and SFA were negatively correlated with IMT. In contrast, in women, none of the obesity-related indices were significantly correlated with stiffness parameter β or IMT. In multiple regression analyses, VFA as well as WC, BMI, and SFA were independently associated with stiffness parameter β after adjustment for age and other potential confounders in men but not in women. None of the obesity-related indices were independently associated with IMT for either sex. Conclusion : In men with T2D, visceral adiposity is associated with carotid arterial stiffness but not thickness.

1 August 2020 in Journal of Atherosclerosis and Thrombosis
Verified
Journal Article
Open access
PDF file
MMMasako Miyashima
Masako Miyashima
TSTetsuo Shoji
Tetsuo Shoji
YKYoshinori Kakutani
Yoshinori Kakutani
YYYuko Yamazaki
Yuko Yamazaki
AOAkinobu Ochi
Akinobu Ochi
MEMasanori Emoto
Masanori Emoto
Aim: Inter-arm blood pressure difference (IAD) is known to be associated with a composite of cardiovascular disease (CVD) and with CVD risk factors. However, only limited information is available regarding the contribution of diabetes mellitus to IAD and the association of IAD with individual CVDs, such as coronary artery disease (CAD), stroke, and peripheral artery disease (PAD). Methods: We addressed these issues in this cross-sectional study of 2580 participants who had simultaneous blood pressure measurements in both arms using an automated device. Results: Compared with 1,264 nondiabetic subjects, 1316 patients with diabetes mellitus had a greater IAD (P=0.01) and a higher prevalence of IAD of ≥ 10 mmHg (8.4% vs. 5.4%, P=0.002). However, such difference was not significant after the adjustment for potential confounders. Among CAD, stroke, and PAD, only PAD was significantly associated with IAD in a model adjusted for the CVD risk factors. Age was found to modify the association between IAD and PAD, with the association being more prominent in the younger subgroup. Conclusion: Thus, diabetes mellitus itself was not an independent factor associated with IAD. A larger IAD was preferentially associated with the presence of PAD, and this association was modified by age.

1 September 1992 in The American Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
MOMitsuru Ohshima
Mitsuru Ohshima
MYMasaru Yamazoe
Masaru Yamazoe
YTYusuke Tamura
Yusuke Tamura
TMTaku Matsubara
Taku Matsubara
MSMasataka Suzuki
Masataka Suzuki
NHNorio Higuma
Norio Higuma

1 January 2021 in Journal of Japanese Society of Oral Medicine
Verified
Journal Article
Open access
PDF file
AKAkiko Kashiwazaki
Akiko Kashiwazaki
YJYoshinori Jinbu
Yoshinori Jinbu
YYYuko Yamazaki
Yuko Yamazaki
MHMoeka Hirano
Moeka Hirano
AYAki Yamamoto
Aki Yamamoto
YMYoshiyuki Mori
Yoshiyuki Mori
超高齢化の現在味覚障害は増加しつつあり,その中で最頻の薬剤性味覚障害は,無視できない問題となっている。したがって,薬剤性味覚障害の周知および対応策の構築が急務となる。今回われわれはアムロジピンベシル酸,トピラマート,テガフール,プレドニゾロンが原因の薬剤性味覚障害4症例について若干の文献的考察を加えてその概要を報告する。